Research and analysis

Young person and adult screening KPI data: Q2 summary factsheets (1 July to 30 September 2022) HTML

Updated 15 June 2023

Applies to England

Please be aware that this data covers the time period through the COVID-19 pandemic. Provider performance should therefore be interpreted with caution.

In addition to this, some providers were justifiably not able to make timely data returns or validate their data in this period. We recommend looking at the historical trend data of services before the COVID-19 pandemic to help interpret the data.

This report should be read in conjunction with the full KPI data tables published each quarter.

1. Abdominal aortic aneurysm screening

1.1 KPI AA2: coverage: initial screen

National performance of AA2 (see standard AAA-S04) in Q2 was 31.8%. AA2 is an annual indicator and quarterly figures are cumulative from Q1 to Q4. England performance is shown in the trend graph below.

Due to the ongoing coronavirus response and restoration of screening this KPI has been impacted. Performance against the KPI has been affected by when providers restarted primary screening, increased appointment lengths, access to venues and availability of screening staff.

Quarter 2 performance

Reporting period Numerator Denominator Performance % Completeness of data %
1 July to 30 September 2022 104,272 327,485 31.8% 100%
Region Performance %
East of England  29.4%
London 32.4%
Midlands 40.9%
North East and Yorkshire 24.7%
North West 18.7%
South East 27.1%
South West 49.9%
England 31.8%

1.2 KPI AA3: coverage: annual surveillance scan

National performance of AA3 (see standard AAA-S05) was withdrawn from publication in Q1 and Q2 2020 to 2021, and also Q1 2021 to 2022. This was due to the impact of the COVID-19 pandemic on screening activity that occurred during these periods.

The trend graph below shows that England AA3 in Q2 was 91.8%, above the acceptable threshold of 85%.

Quarter 2 performance

Reporting period Numerator Denominator Performance % Completeness of data %
1 July to 30 September 2022 4,259 4,640 91.8% 100%
Region Performance %
East of England  95.2%
London 87.4%
Midlands 94.9%
North East and Yorkshire 87.0%
North West 91.3%
South East 90.0%
South West 92.8%
England 91.8%

1.3 KPI AA4: coverage: quarterly surveillance scan

National performance of AA4 (see standard AAA-S06) was withdrawn from publication in Q1 and Q2 2020 to 2021 due to the impact of the COVID-19 pandemic on screening activity. The trend graph below shows that England AA4 in Q2 2022 to 2023 was 92.4%, higher than the previous quarter and above the acceptable threshold of 90%.

28 out of 38 screening services met the acceptable threshold, and 13 of those met the achievable threshold of 95%.

Quarter 2 performance

Reporting period Numerator Denominator Performance % Completeness of data %
1 July to 30 September 2022 2,514 2,722 92.4% 100%
Region Performance %
East of England  92.2%
London 92.4%
Midlands 92.9%
North East and Yorkshire 90.1%
North West 89.6%
South East 90.6%
South West 96.7%
England 92.4%

2. Diabetic eye screening

2.1 KPI DE1: uptake: routine digital screening

National performance of DE1 (see standard DES-S07) in Q2 was 78.3%, lower than the previous quarter. The trend graph below shows that England DE1 performance has been above the acceptable threshold of 75% for five consecutive quarters. All 57 screening services submitted data. DE1 is an annual rolling figure.

Due to the ongoing coronavirus response and restoration of screening this KPI may be impacted. Local services should highlight this with their commissioners where they consider that this KPI has been impacted by the COVID-19 response.

Quarter 2 performance

Reporting period Numerator Denominator Performance % Completeness of data %
1 July to 30 September 2022 2,340,376 2,987,309 78.3% 100%
Region Performance %
East of England  82.6%
London 78.4%
Midlands 72.9%
North East and Yorkshire 79.0%
North West 75.7%
South East 82.0%
South West 82.7%
England 78.3%

2.2 KPI DE2: test: timeliness of results letters

National performance of DE2 (see standard DES-S10) in Q2 was 95.8%, higher than the previous quarter. The trend graph below shows that England DE2 performance rose above the achievable threshold of 95%. All 57 screening services submitted data. 55 services met the acceptable threshold of 70% and 48 met the achievable threshold of 95%.

Due to the ongoing coronavirus response and restoration of screening this KPI may be impacted. Local services should highlight this with their commissioners where they consider that this KPI has been impacted by the COVID-19 response.

Quarter 2 performance

Reporting period Numerator Denominator Performance % Completeness of data %
1 July to 30 September 2022 665,288 694,151 95.8% 100%
Region Performance %
East of England  99.8%
London 98.5%
Midlands 90.3%
North East and Yorkshire 97.4%
North West 89.8%
South East 99.8%
South West 96.9%
England 95.8%

2.3 KPI DE3: intervention/treatment: timely consultation for people with diabetes who are screen positive

National performance of DE3 (see standard DES-S12) in Q1 was 64.7%, higher than the previous quarter. The trend graph below shows that England DE3 performance has remained below the acceptable threshold of 80% since 1 April 2019. All 57 screening services submitted data and 11 met the acceptable threshold.

Due to the ongoing coronavirus response and restoration of screening this KPI may be impacted. Local services should highlight this with their commissioners where they consider that this KPI has been impacted by the COVID-19 response.

Quarter 2 performance

Reporting period Numerator Denominator Performance % Completeness of data %
1 July to 30 September 2022 1,819 2,810 64.7% 100%
Region Performance %
East of England  56.7%
London 74.6%
Midlands 69.7%
North East and Yorkshire 66.8%
North West 57.6%
South East 62.6%
South West 62.1%
England 64.7%

2.4 KPI DE4: uptake: repeat non-attenders

DE4 (see standard DES-S08) was introduced in 2022 to 2023.

In Q2 2022 to 2023, national performance of DE4 was 11.7%.

All 57 screening services submitted data. 8 met the acceptable threshold of 8.0% and 3 of them met the achievable threshold of 5.0%.

Quarter 2 performance

Reporting period Numerator Denominator Performance % Completeness of data %
1 July to 30 September 2022 257,998 2,198,361 11.7% 100%
Region  Performance %
East of England  8.8%
London 10.5%
Midlands 15.4%
North East and Yorkshire 11.1%
North West 13.5%
South East 10.5%
South West 9.4%
England 11.7%

3. Bowel cancer screening

3.1 KPI BCS1: uptake

National performance of BCS1 (see standard BCSP-S02) in Q2 was 66.1%, lower than the previous quarter. Publication of BCS1 was withdrawn for Q1 2020 to 2021 due to the impact of COVID-19 on screening activity. The trend graph below shows that England BCS1 performance has remained above the acceptable threshold of 52% since 1 April 2019.

Out of 64 screening services, 62 of them met the acceptable threshold and 55 met the achievable threshold of 60%.

Quarter 2 performance

Reporting period Numerator Denominator Performance % Completeness of data %
1 July to 30 September 2022 990,966 1,498,061 66.1% 100%
Region Performance %
East of England  68.4%
London 55.8%
Midlands 66.1%
North East and Yorkshire 68.4%
North West 63.8%
South East 68.8%
South West 70.5%
England 66.1%

3.2 KPI BCS2: coverage

National performance of BCS2 (see standard BCSP-S01) in Q1 was 70.7%, the highest published level recorded for this KPI. See the corresponding data tables for Q1 2022 to 2023 for full details.

BCS2 is available 6 months (2 quarters) in arrears. The trend graph below shows England BCS2 performance since 1 April 2018. There are no thresholds set for this KPI.

Q1 Coverage ranged from 62.1% in London to 74.5% in the South West.

Quarter 1 performance

Reporting period Numerator Denominator Performance % Completeness of data %
1 April to 30 June 2022 6,503,155 9,198,495 70.7% 100%
Region Performance %
East Midlands 72.2%
East of England 72.4%
London 62.1%
North East 72.8%
North West 68.7%
South East 73.1%
South West 74.5%
West Midlands 69.2%
Yorkshire and the Humber 72.7%
England 70.7%

4. Breast screening

4.1 KPI BS1: uptake

National performance of BS1 (see standard BSP-S03) in Q2 was 56.7%. The England trend graph below shows that publication of this KPI was withdrawn from Q1 to Q4 2020 to 2021 as there were issues with data quality due to the impact of the COVID-19 pandemic on screening services.

Provisional quarterly data should be used with caution to measure performance as it will contain a proportion of women who were invited but have not yet attended the appointment. Data on this indicator will only be accurate 6 months after the end of the reporting period.

Quarter 2 performance

Reporting period Numerator Denominator Performance % Completeness of data %
1 July to 30 September 2022 449,425 792,925 56.7% 100%
Region Performance %
East of England  57.7%
London 44.6%
Midlands 55.2%
North East and Yorkshire 59.4%
North West 62.8%
South East 63.8%
South West 55.5%
England 56.7%

4.2 KPI BS2: uptake: screening round length

National performance of BS2 (see standard BSP-S04) in Q2 was 63.7%. The England trend graph below shows that publication of this KPI was withdrawn from Q1 to Q4 2020 to 2021 as there were issues with data quality due to the impact of the COVID-19 pandemic on screening services.

Quarter 2 performance

Reporting period Numerator Denominator Performance % Completeness of data %
1 July to 30 September 2022 379,961 596,777 63.7% 100%
Region Performance %
East of England  71.0%
London 61.7%
Midlands 57.4%
North East and Yorkshire 70.9%
North West 51.2%
South East 68.6%
South West 68.9%
England 63.7%

5. Cervical screening

5.1 KPI CS1: coverage under 50 years

National performance of CS1 (see standard CSP-S01) in Q2 was 67.1%, which was lower than the previous quarter. The trend graph below shows that CS1 performance has remained below the acceptable threshold of 80% since 1 April 2019.

On April 1 2021, 38 CCGs merged creating 9 new ones, resulting in a total of 106 CCGs in England. None of the 106 CCGs met the acceptable threshold.

Quarter 2 performance

Reporting period Numerator Denominator Performance % Completeness of data %
1 July to 30 September 2022 7,028,084 10,472,750 67.1% 100%
Region Performance %
East of England  70.1%
London 60.1%
Midlands 67.8%
North East and Yorkshire 70.3%
North West 67.5%
South East 68.6%
South West 71.3%
England 67.1%

5.2 KPI CS2: coverage 50 years and above

National performance of CS2 (see standard CSP-S02) in Q2 was 74.8%, lower than the previous quarter. The trend graph below shows that CS2 performance has remained below the acceptable threshold of 80% since 1 April 2019.

On April 1 2021, 38 CCGs merged creating 9 new ones, resulting in a total of 106 CCGs in England. None of the 106 CCGs met the acceptable threshold.

Quarter 2 performance

Reporting period Numerator Denominator Performance % Completeness of data %
1 July to 30 September 2022 4,007,137 5,360,285 74.8% 100%
Region Performance %
East of England  76.2%
London 71.4%
Midlands 75.2%
North East and Yorkshire 76.1%
North West 73.6%
South East 75.0%
South West 76.3%
England 74.8%